The DOI matches its Crossref record; 15 of the 15 references it cites were found in a registry or an index.
Prediction of Indolent Prostate Cancer: Validation and Updating of a Prognostic Nomogram
Abstract
PURPOSE: Screening with serum prostate specific antigen testing leads to the detection of many prostate cancers early in their natural history. Statistical models have been proposed to predict indolent cancer. We validated and updated model predictions for a screening setting. MATERIALS AND METHODS: We selected 247 patients with clinical stage T1C or T2A from the European Randomized Study on Screening for Prostate Cancer who were treated with radical prostatectomy. We validated a nomogram that had previously been developed in a clinical setting. Predictive characteristics were serum prostate specific antigen, ultrasound prostate volume, clinical stage, prostate biopsy Gleason grade, and total length of cancer and noncancer tissue in biopsy cores. Indolent cancer was defined as pathologically organ confined cancer 0.5 cc or less in volume without poorly differentiated elements. Logistic regression was used to update the previous model and examine the contribution of other potential predictors. RESULTS: Overall 121 of 247 patients (49%) had indolent cancer, while the average predicted probability was around 20% (p <0.001). Effects of individual variables were similar to those found before and discriminative ability was adequate (AUC 0.76). An updated model was constructed, which merely recalibrated the nomogram and did not apply additional predictors. CONCLUSIONS: Prostate cancers identified in a screening setting have a substantially higher likelihood of being indolent than those predicted by a previously proposed nomogram. However, an updated model can support patients and clinicians when the various treatment options for prostate cancer are considered.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Jemal, A., Bray, F., Center, M. M., Ferlay, J., Ward, E., & Forman, D. (2011) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.20107 · Cited by 54,679
Global Cancer Statistics, 2002
Parkin, D. M., Bray, F., Ferlay, J., & Pisani, P. (2005) · CA: A Cancer Journal for Clinicians · doi:10.3322/canjclin.55.2.74 · Cited by 18,196
Steyerberg, E. W., Eijkemans, M. J. C., Harrell, F. E., & Habbema, J. D. F. (2000) · Statistics in Medicine · doi:10.1002/(sici)1097-0258(20000430)19:8<1059::aid-sim412>3.0.co;2-0 · Cited by 785
Self-citationNatural History of Early, Localized Prostate Cancer
Johansson, J.-E. (2004) · JAMA · doi:10.1001/jama.291.22.2713 · Cited by 703
Two Further Applications of a Model for Binary Regression
Cox, D. R. (1958) · Biometrika · doi:10.2307/2333203 · Cited by 557
Two further applications of a model for binary regression
COX, D. R. (1958) · Biometrika · doi:10.1093/biomet/45.3-4.562 · Cited by 556
Steyerberg, E. W., Borsboom, G. J. J. M., van Houwelingen, H. C., Eijkemans, M. J. C., & Habbema, J. D. F. (2004) · Statistics in Medicine · doi:10.1002/sim.1844 · Cited by 552
Self-citationKATTAN, M. W., EASTHAM, J. A., WHEELER, T. M., MARU, N., SCARDINO, P. T., ERBERSDOBLER, A., GRAEFEN, M., HULAND, H., KOH, H., SHARIAT, S. F., et al. (2003) · Journal of Urology · doi:10.1097/01.ju.0000091806.70171.41 · Cited by 350
Self-citationJudging New Markers by Their Ability to Improve Predictive Accuracy
Kattan, M. W. (2003) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/95.9.634 · Cited by 265
Self-citationA strategy for modelling the effect of a continuous covariate in medicine and epidemiology
Royston, P. (2000) · Statistics in Medicine · doi:10.1002/1097-0258(20000730)19:14<1831::aid-sim502>3.0.co;2-1 · Cited by 219
Cited by
Screening and Prostate-Cancer Mortality in a Randomized European Study
Schröder, F. H., Hugosson, J., Roobol, M. J., Tammela, T. L. J., Ciatto, S., Nelen, V., Kwiatkowski, M., Lujan, M., Lilja, H., Zappa, M., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0810084 · Cited by 4,014
Self-citationHow To Build and Interpret a Nomogram for Cancer Prognosis
Iasonos, A., Schrag, D., Raj, G. V., & Panageas, K. S. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2007.12.9791 · Cited by 3,222
Calibration: the Achilles heel of predictive analytics
On behalf of Topic Group ‘Evaluating diagnostic tests and prediction models’ of the STRATOS initiative, Van Calster, B., McLernon, D. J., van Smeden, M., Wynants, L., & Steyerberg, E. W. (2019) · BMC Medicine · doi:10.1186/s12916-019-1466-7 · Cited by 2,650
Self-citationIlic, D., Neuberger, M. M., Djulbegovic, M., & Dahm, P. (2013) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd004720.pub3 · Cited by 1,150
Quality-of-Life Effects of Prostate-Specific Antigen Screening
Heijnsdijk, E. A. M., Wever, E. M., Auvinen, A., Hugosson, J., Ciatto, S., Nelen, V., Kwiatkowski, M., Villers, A., Páez, A., Moss, S. M., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1201637 · Cited by 427
Self-citation
Metadata
- Authors
- Steyerberg, E. W., Roobol, M. J., Kattan, M. W., van der Kwast, T. H., de Koning, H. J., & Schröder, F. H.
- Venue
- Journal of Urology
- Published
- 2007-01
- Volume
- 177
- Issue
- 1
- Pages
- 107-112
- ISSN
- 0022-5347 (ISSN-L)
- 1527-3792
- OpenAlex
- W2163195821
- Cited by
- 304
- References
- 15
- FWCI
- 30.32
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Prediction of Indolent Prostate Cancer: Validation and Updating of a Prognostic Nomogram. https://app.cochat.ai/papers/10.1016/j.juro.2006.08.068
- The paper
- Steyerberg, E. W., Roobol, M. J., Kattan, M. W., van der Kwast, T. H., de Koning, H. J., & Schröder, F. H. (2007). Prediction of Indolent Prostate Cancer: Validation and Updating of a Prognostic Nomogram. Journal of Urology. https://doi.org/10.1016/j.juro.2006.08.068
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.